Is Now The Time To Sell Vodafone Group Plc?

Shares in telecoms giant Vodafone Group plc (LON: VOD) are up 26% so far this year. Could their rise continue?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At the beginning of 2013, shares in Vodafone (LSE: VOD) (NASDAQ: VOD.US) were 155p, their lowest price since 2010. Brave buyers at this point were well rewarded. From this low, the Vodafone share price did not look back, hitting 200p in late May.

However, the shares have not hit those highs since. In fact, in the last three months, the shares are down 1.1%, versus a 1.9% advance for the FTSE 100 index. At one point in June, the shares fell to 176p — more than 10% below the level of just one month previous.

This year, Vodafone has been a tale of two continents. The bull case for the stock centres on the value in the company’s North American joint venture Verizon Wireless. The bears, however, have been focusing on the company’s struggles in Europe.

The rise to 200p coincided with speculation that Vodafone might receive an offer for its stake in Verizon Wireless from its venture partner Verizon Communications.

Share price falls have normally followed announcements on European trading, such as the news earlier in July that UK and German revenues were both down by around 5%. Southern Europe showed even bigger declines.

Prospects

Vodafone’s mobile service is regarded by its consumers as a must-have service. However, unlike electricity and gas, the price of mobile calls and data have been falling as a result of competition and European regulation.

As for Verizon Wireless, while its value is not fully recognised in the Vodafone share price, I do not expect a bid to arrive any time soon.

Earnings fears for the group are encapsulated in broker forecasts for 2014. Today, the consensus forecasts for the full year are at their lowest for 12 months.

Valuation

Those forecasts put Vodafone shares on a P/E for the year of 12.0 times earnings. Modest earnings per share growth is forecast for the following year, pushing the P/E down to 11.3.

Last year’s dividend payout amounted to a 5.3% yield. Another two years of payout increases are forecast. A yield of 5.5% is expected for this year, rising to 5.6% the year after.

Verdict

The forecast dividend rises are smaller than in previous years. I sold my Vodafone shares recently at 193p and will not buy back unless the shares are trading for less than 165p.

Although Vodafone remains one of the best income shares available, our analysts here at the Motley Fool believe that they have identified a better dividend prospect. “The Motley Fool’s Top Income Share For 2013” is a free research report detailing their top pick. Just click here to get your copy today.

> David does not own shares in any of the companies mentioned. The Motley Fool has recommended shares in Vodafone.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Investing Articles

Investing £10K into this FTSE 100 giant could bag me a second income worth £980

This Fool explains how dividend investing in the right picks could help build a second income stream, as well as…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

The Nasdaq just tanked. Here are 3 US growth stocks to consider for an ISA now

These Nasdaq stocks have a lot of potential in the long run and Edward Sheldon believes they could be worth…

Read more »

Investing Articles

Potentially 42% undervalued, is this FTSE 100 company a sleeping giant?

The FTSE 100 is full of opportunities for the patient investor, and I think I may have found one that…

Read more »

Investing Articles

AstraZeneca, a mega-cap growth stock that just got cheaper!

Our writer takes a closer look at this growth stock -- which also happens to be the largest company of…

Read more »

Investing Articles

How I’d invest £5,000 in FTSE growth stocks right now

Sumayya Mansoor explains why she’s bullish about these FTSE growth stocks, and would be willing to buy some shares.

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

ITV shares down after revenue guidance cut in first-half interim results

After releasing results this morning, the ITV share price slumped. But with several metrics looking positive, how will this effect…

Read more »

Investing Articles

This FTSE 100 stock’s down 50%, and a director just bought 8,000 shares

Directors of this blue-chip company have been snapping up a load of its shares. Should I do likewise and buy…

Read more »

Investing Articles

The BT share price is far too cheap, analysts say!

The BT share price fell on Thursday 25 July after the company's Q1 results. Dr James Fox takes a closer…

Read more »